A Novel Acetylation-Immune Subtyping for the Identification of a BET Inhibitor-Sensitive Subgroup in Melanoma

SIMPLE SUMMARY: BET inhibitors (BETis) are a class of promising therapies that inhibit the growth of melanoma cells. However, how to identify BETi-sensitive subtypes of melanoma is still unclear. We analyzed 48 melanoma cell lines and 104 melanoma patients and identified two acetylation-immune subty...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Liuying, Zhang, Liuchao, Li, Shuang, Cao, Lei, Li, Kang, Zhao, Weiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383501/
https://www.ncbi.nlm.nih.gov/pubmed/37513949
http://dx.doi.org/10.3390/ph16071037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383501/
https://www.ncbi.nlm.nih.gov/pubmed/37513949
http://dx.doi.org/10.3390/ph16071037

Ejemplares similares